MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders (opens original article in a new tab)
MediPharm Labs reported the voting results from its 2026 shareholder meeting, including board changes and approvals for director numbers.
- MediPharm Labs announced voting results from its 2026 Annual and Special Meeting of Shareholders.
- Keith Strachan was re-elected as a director and appointed Chair of the Board.
- Shareholders approved resolutions to set the number of directors at five and authorize directors to adjust the board size.
Conversation
No comments yet
Threaded discussion is coming next — this is where the community conversation about this story will live.